PuSH - Publikationsserver des Helmholtz Zentrums München

Müller-Nedebock, A.C.* ; Wenzel, E. ; Pfäffle, R.*

Uniparental disomy leads to a novel cause of MC2R-related familial glucocorticoid deficiency type 1.

Eur. J. Endocrinol. 193, K5-K10 (2025)
Postprint DOI PMC
Open Access Green
Familial Glucocorticoid Deficiency Type 1 (FGD1) is a rare autosomal recessive disease caused by pathogenic variants in the MC2R gene. This case report presents the first documented instance of FGD1 caused by a homozygous 1.421 kb deletion affecting the non-coding promoter region of MC2R. The patient, a 9-year-old girl, presented with severe cortisol insufficiency and hyperpigmentation starting at birth. Genetic testing initially missed the deletion, as standard whole-exome sequencing in 2016 did not include a copy number variation analysis. However, a whole-genome sequencing analysis in 2024 identified the deletion. The variant was inherited through paternal uniparental disomy (UPD), a rare genetic mechanism that caused the homozygous state. This case underscores the value of utilizing current genetic testing approaches, especially in cases where clinical features strongly suggest a genetic etiology despite inconclusive initial genetic testing results. Additionally, it highlights the need to consider non-coding regions and UPD in genetic diagnostics.
Impact Factor
Scopus SNIP
Altmetric
5.200
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Mc2r ; Fgd1 ; Glucocorticoid Deficiency ; Upd 18 ; Non-coding; Acth Receptor; Mutations; Promoter
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0804-4643
e-ISSN 1479-683X
Quellenangaben Band: 193, Heft: 2, Seiten: K5-K10 Artikelnummer: , Supplement: ,
Verlag BioScientifica
Verlagsort Great Clarendon St, Oxford Ox2 6dp, England
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-506503-001
Förderungen AI-assisted technologies in the writing process
German Research Foundation
Scopus ID 105013250987
PubMed ID 40729435
Erfassungsdatum 2025-08-01